PI
TARO

PEAK6 Investments’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

PEAK6 Investments’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,616
Closed -$363K – 5284
2020
Q3 		$363K Buy
6,616
+2,984
+82% +$186K ﹤0.01% 3093
2020
Q2 		$241K Sell
3,632
-1,598
-31% -$107K ﹤0.01% 3263
2020
Q1 		$320K Buy
+5,230
New +$388K ﹤0.01% 2447

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PEAK6 Investments's TARO Position: Q4 2020 in Review

PEAK6 Investments sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2020, closing a stake of 6,616 shares — an estimated $363K sold.

PEAK6 Investments first reported a position in TARO in Q1 2020 and held it in 3 quarters. The position peaked at $363K in Q3 2020. 84 funds tracked by Wall St. Rank hold TARO as of Q4 2020.

  • PEAK6 Investments reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2020 after selling out during the quarter.
  • PEAK6 Investments sold 6,616 Taro Pharmaceutical Industries Ltd. shares in Q4 2020, an estimated $363K.
  • PEAK6 Investments first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2020 and held it in 3 quarters.
  • PEAK6 Investments's Taro Pharmaceutical Industries Ltd. position peaked at $363K in Q3 2020.
  • 84 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2020.

Based on PEAK6 Investments's 13F filing for Q4 2020, filed 12 Feb 2021.